AVK-101-301
The goal of this clinical trial is to learn if ARD-101 works to treat hyperphagia-related behavior in patients with Prader-Willi syndrome (PWS). It will also teach us about the safety of ARD-101.
The main questions it aims to answer are:
Does…
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 13 Years - N/A
- Sexes
- All
RM-493-043
This is a Phase 2, open-label study designed to assess the safety and efficacy of setmelanotide in patients with obesity due to Prader-Willi Syndrome (PWS) who are 6 to 65 years of age. Up to 20 patients are planned to be enrolled. Patients will…
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 6 Years - 65 Years
- Sexes
- All
Leptin/Adiponectin Ratio Study
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates